Nutritional considerations in adult cardiothoracic surgical patients

Surgical Clinics of North America

Volumn 91, Issue 4, 2011, Pages 857-875

  Sanchez, Juan A ^a,b   Sanchez, Lise L ^c   Dudrick, Stanley J ^a,d  

^a ST MARY S HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c BRIDGEPORT HOSPITAL   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac cachexia; Cardiac surgery; Chronic heart failure; Malnutrition risk factors; Nutrition; Thoracic surgery

Indexed keywords

ALDOSTERONE ANTAGONIST; AMINO ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; MINERAL; PROTEIN; SERUM ALBUMIN; VITAMIN;

BODY MASS; CACHEXIA; CARDIAC CACHEXIA; CARDIAC RESYNCHRONIZATION THERAPY; CHYLOTHORAX; CORONARY ARTERY BYPASS GRAFT; DIET SUPPLEMENTATION; ENERGY CONSUMPTION; ENTERIC FEEDING; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE METABOLISM; HEART PERFUSION; HEART SURGERY; HUMAN; HYPERGLYCEMIA; LENGTH OF STAY; MALNUTRITION; METABOLIC REGULATION; NUTRITIONAL DEFICIENCY; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; OBESITY; OXIDATIVE PHOSPHORYLATION; PARENTERAL NUTRITION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; PROTEIN DIET; PROTEIN SYNTHESIS; REVIEW; SODIUM RESTRICTION; SURGICAL PATIENT; SURGICAL RISK; THORAX DRAINAGE; THORAX SURGERY; WEIGHT REDUCTION;

ADULT; CACHEXIA; CARDIAC SURGICAL PROCEDURES; DIETARY SUPPLEMENTS; HEART FAILURE; HUMANS; MALNUTRITION; NUTRITIONAL REQUIREMENTS; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; POSTOPERATIVE COMPLICATIONS; SERUM ALBUMIN;

EID: 79960620816     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2011.06.001     Document Type: Review

References (112)

1. Rich M.W., Keller A.J., Schechtman K.B., et al. Increased complications and prolonged hospital stay in elderly cardiac surgical patients with low serum albumen. Am J Cardiol 1989, 63:714-718.
2. Loop F.D., Golding L.R., Macmillan J.P., et al. Coronary artery surgery in women compared to men: analyses of risks and long-term results. J Am Coll Cardiol 1983, 1:383-390.
3. Engelman D.T., Adams D.H., Burne J.G., et al. Impact of body mass index and albumin on morbidity and mortality after cardiac surgery. J Thorac Cardiovasc Surg 1999, 118:866-873.
4. Habib R.H., Zacharias A., Schwann T.A., et al. Effects of obesity and small body size on operative and long-term outcomes of coronary artery bypass surgery: a propensity-matched analysis. Ann Thorac Surg 2005, 79(6):1976-1986.
5. Gibbs J., Cull W., Henderson W., et al. Preoperative serum albumin level as a predictor of operative mortality and morbidity. Arch Surg 1999, 134:36-42.
6. Keys A., Fidanza F., Karvonen M.J., et al. Indices of relative weight and obesity. J Chronic Dis 1972, 25:329-343.
7. Criqui M.H., Klauber M.R., Barrett-Conner E.L., et al. Adjustment for obesity in studies of cardiovascular disease. Am J Epidemiol 1982, 116:685-691.
8. Rady M.Y., Ryan T., Starr N.J. Clinical characteristics of preoperative hypoalbuminemia predict outcome of cardiovascular surgery. JPEN J Parenter Enteral Nutr 1997, 21:81-90.
9. Moulton M.J., Cresswell L.L., Mackey M.E., et al. Obesity is not a risk factor for significant adverse outcomes after cardiac surgery. Circulation 1996, 94(Suppl):II87-II92.
10. Christakis G.T., Weisel R.D., Buth K.J., et al. Is body size the cause for poor outcomes of coronary artery bypass operations in women?. J Thorac Cardiovasc Surg 1995, 110:1344-1358.
11. Fisher L.D., Kennedy J.W., Davis K.B., et al. Association of sex, physical size, and operative mortality after coronary artery bypass in the Coronary Artery Surgery Study (CASS). J Thorac Cardiovasc Surg 1982, 84:334-341.
12. O'Conner G.T., Morton J.R., Diehl M.J., et al. Differences between men and women in hospital mortality associated with coronary artery bypass graft surgery. Circulation 1993, 88:2104-2110.
13. Mickleborough L.L., Takagi Y., Maruyama H., et al. Is sex a factor in determining operative risk for aortocoronary bypass graft surgery?. Circulation 1995, 92(Suppl):II80-II84.
14. van Venrooij L.M., de Vos R., Borgmeijer-Hoelen M.M., et al. Preoperative unintended weight loss and low body mass index in relation to complications and length of stay after cardiac surgery. Am J Clin Nutr 2008, 87(6):1656-1661.
15. Keith M., Mokbel R., San Emeterio M., et al. Evaluation of taste sensitivity in patients undergoing coronary artery bypass graft surgery. J Am Diet Assoc 2010, 110(7):1072-1077.
16. Abel R.M., Fischer J.E., Buckley M.J., et al. Malnutrition in cardiac surgery patients. Arch Surg 1976, 111:45-50.
17. Visser M., Davids M., Verberne H.J., et al. Rationale and design of a proof-of-concept trial investigating the effect of uninterrupted perioperative (par)enteral nutrition on amino acid profile, cardiomyocytes structure, and cardiac perfusion and metabolism of patients undergoing coronary artery bypass grafting. J Cardiothorac Surg 2011, 6:36-43.
18. Umenai T., Nakajima Y., Sessler D.I., et al. Perioperative amino acid infusion improves recovery and shortens the duration of off-pump coronary artery bypass grafting. Anesth Analg 2006, 103(6):1386-1393.
19. Jeejeebhoy F., Keith M., Freeman M., et al. Nutrition supplementation with MyoVive repletes essential cardiac myocyte nutrients and reduces left ventricular size in patients with left ventricular dysfunction. Am Heart J 2002, 143(6):1092-1100.
20. Tepaske R., Velthius H., Oudemans-van Straaten H.M., et al. Effect of preoperative oral immune enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: a randomised placebo controlled trial. Lancet 2001, 358(9283):696-701.
21. Anker S.D., Coates A.J.S. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. Chest 1999, 115:836-847.
22. Kannel W.B., Belanger A.J. Epidemiology of heart failure. Am Heart J 1991, 121:951-957.
23. Cowie M.R., Mosterd A.A., Wood D.A., et al. The epidemiology of heart failure. Eur Heart J 1997, 18:208-225.
24. Katz A.M., Katz P.B. Diseases of the heart in works of Hippocrates. Br Heart J 1962, 24:257-264.
25. Aronson J.K. An account of the foxglove and its medical uses 1985, Oxford University Press, London, p. 11-100.
26. Carr J.G., Stevenson L.W., Walden J.A., et al. Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1989, 63:709-713.
27. McMurray J., Abdullah I., Dargie H.J., et al. Increased concentrations of tumor necrosis factor in " cachectic" patients with severe chronic heart failure. Br Heart J 1991, 66:356-358.
28. Levine B., Kalman J., Mayer L., et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990, 323:236-241.
29. Otaki M. Surgical treatment of patients with cardiac cachexia: an analysis of factors affecting operative mortality. Chest 1994, 105:1347-1351.
30. Pittman J.G., Cohen P. The pathogenesis of cardiac cachexia. N Engl J Med 1964, 271:403-409.
31. King D., Smith M.L., Chapman T.J., et al. Fat malabsorption in elderly patients with cardiac cachexia. Age Ageing 1996, 25:144-149.
32. King D., Smith M.L., Lye M. Gastro-intestinal protein loss in elderly patients with cardiac cachexia. Age Ageing 1996, 25:221-223.
33. Braunwald E. Clinical manifestation of heart failure. Heart disease. A textbook of cardiovascular medicine 1984, vol. 1:499. WB Saunders, Philadelpha.
34. MacGowan G.A., Mann D.L., Kormos R.L., et al. Circulation IL-6 in severe heart failure. Am J Cardiol 1997, 79:1128-1131.
35. Anker S.D., Chua T.P., Swan J.W., et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure: the importance for cardiac cachexia. Circulation 1997, 96:526-534.
36. Mancini D.M., Walter G., Reichek N., et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 1992, 85:1364-1373.
37. Vescovo G., Serafini F., Facchin L., et al. Specific changes in skeletal muscle myosin heavy chains composition in cardiac failure: differences compared with disuse atrophy as assessed on microbiopsies by high resolution electrophoresis. Heart 1996, 76:337-343.
38. Simonini A., Long C.S., Dudley G.A., et al. Heart failure in rats causes changes in skeletal muscle morphology and gene expression that are not explained by reduced activity. Circ Res 1996, 79(1):128-136.
39. Broqvist M., Arnqvist H., Dahlstrom U., et al. Nutritional assessment and muscle energy metabolism in severe congestive heart failure: effects of long-term dietary supplementation. Eur Heart J 1994, 15:1641-1650.
40. Heymsfield S.B., Casper K. Congestive heart failure: clinical management by use of continuous nasoenteric feeding. Am J Clin Nutr 1989, 50:539-544.
41. Neubauer S. The failing heart - an engine out of fuel. N Engl J Med 2007, 356:1140-1151.
42. McMurray J.J., Pfeffer M.A. Heart failure. Lancet 2005, 365:1877-1889.
43. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987, 316:1429-1435.
44. Pfeffer M.A., Braunwald E., Moye L.A., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. N Engl J Med 1992, 327:669-677.
45. Pitt B., Zannad F., Remme W.J., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999, 341:709-717.
46. CIBIS Investigators and Committees. A randomized trial β-blockade in heart failure: the Cardiac Bisoprolol Insufficiency Study (CIBIS). Circulation 1994, 90:1765-1773.
47. Packer M., Bristow M.R., Cohen J.N., et al. The effect of carvedilol on morbidity and mortality on patients with chronic heart failure. N Engl J Med 1996, 334:1349-1355.
48. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004, 350:2140-2150.
49. Cleland J.G., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005, 352:1539-1549.
50. Mann D.L., Bristow M.R. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 2005, 111:2837-2849.
51. Hermann G., Decherd G.M. The chemical nature of heart failure. Ann Intern Med 1939, 12:1233-1244.
52. Wollenberger A. On the energy-rich phosphate supply of the failing heart. Am J Physiol 1947, 150:733-736.
53. Olson R.E., Schwartz W.B. Myocardial metabolism in congestive failure. Medicine (Baltimore) 1951, 30:21-41.
54. Olson R.E. Myocardial metabolism in congestive heart failure. J Chronic Dis 1959, 9:442-464.
55. Ingwall J.S., Weiss R.G. Is the failing heart energy starved? On using the chemical energy to support cardiac function. Circ Res 2004, 95:135-145.
56. Taegtmeyer H. Metabolism - the lost child of cardiology. J Am Coll Cardiol 2000, 36:1386-1388.
57. Taegtmeyer H. Cardiac metabolism as a target for the treatment of heart failure. Circulation 2004, 110:894-896.
58. Stanley W.C., Recchia F.A., Lopaschuk G.D. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 2005, 85:1093-1129.
59. Ventura-Clapier R., Garnier A., Veksler V. Energy metabolism in heart failure. J Physiol 2004, 556:1-13.
60. Morrow D.A., Givertz M.M. Modulation of myocardial energetics; emerging evidence for a therapeutic target in cardiovascular disease. Circulation 2005, 112:3218-3221.
61. Lopaschuk G.D., Rebeyka I.M., Allard M.F. Metabolic modulation: a means to mend a broken heart. Circulation 2002, 105:140-142.
62. Essop M.F., Opie L.H. Metabolic therapy for heart failure. Eur Heart J 2004, 25:1765-1768.
63. van Bilsen M., Smeets P.J., Gilde A.J., et al. Metabolic remodeling of the failing heart: the cardiac burn-out syndrome?. Cardiovasc Res 2004, 61:218-226.
64. Cohn J.M., Tognoni G. A randomized trial of angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001, 345:1667-1675.
65. Pfeffer M.A., Swedberg K., Granger C.B., et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 2003, 362:759-766.
66. Katz A.M. Heart failure: Pathophysiology, molecular biology and clinical management 2000, Lippincott Williams & Wilkins, Philadelphia.
67. Bessman S.P., Geiger P.J. Transport of energy and muscle: the phosphorylcreatine shuttle. Science 1981, 211:448-452.
68. Ingwall J.S. ATP and the heart 2002, Kluwer Academic, Norwell (MA).
69. Wallimann T., Wyss M., Brdiczka D., et al. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the " phosphocreatine circuit" for cellular energy homeostasis. Biochem J 1992, 281:21-40.
70. Wyss M., Wallimann T. Creatine metabolism and the consequences of creatine depletion in muscle. Mol Cell Biochem 1994, 133:51-66.
71. Garlick P.B., Radda G.K., Selly P.J. Phosphorus NMR studies on perfused heart. Biochem Biophys Res Commun 1977, 74:1256-1262.
72. Inwall J.S. Phosphorus nuclear magnetic resonance spectroscopy of cardiac and skeletal muscles. Am J Physiol 1982, 242:H729-H744.
73. Bottomley P.A. MR spectroscopy of the human heart: the status and the challenges. Radiology 1994, 191:593-612.
74. Neubauer S. Cardiac magnetic resonance spectroscopy. Cardiovascular magnetic resonance: established and emerging applications 2003, 39-60. Martin Dunitz, London. A.C. Lardo, Z.A. Fayad, N.A. Chronos (Eds.).
75. Vitale G.D., deKemp R.A., Ruddy T.D., et al. Myocardial glucose utilization and optimization of (18)FDG PET imaging in patients non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction. J Nucl Med 2001, 42:1730-1736.
76. Wallhus T.R., Taylor M., DeGrado T.R., et al. Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure. Circulation 2001, 103:2441-2446.
77. Davila-Roman V.G., Vedala G., Herrero P., et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2002, 40:271-277.
78. Lewandowski E.D. Cardiac carbon 13 magnetic resonance spectroscopy: on the horizon or over the rainbow?. J Nucl Cardiol 2002, 9:419-428.
79. Ning X.H., Zhang J., Liu J., et al. Signaling and expression for mitochondrial membrane proteins during left ventricular remodeling and contractile failure after myocardial infarction. J Am Coll Cardiol 2000, 36:282-287.
80. Gudbjarnason S., Mathes P., Ravens K.G. Functional compartmentation of ATP and creatine phosphate in heart muscle. J Mol Cell Cardiol 1970, 1:325-339.
81. Colagrande L., Formica F., Porta F., et al. L-arginine effects on myocardial stress in cardiac surgery: preliminary results. Ital Heart J 2005, 6:904-910.
82. Quyyumi A.A., Dakak N., Dodati J.G., et al. Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilation. J Am Coll Cardiol 1997, 30:1220-1227.
83. Wallace A.W., Ratcliffe M.B., Galindez D., et al. L-arginine infusion dilates coronary vasculature in patients undergoing coronary bypass surgery. Anesthesiology 1999, 90:1577-1586.
84. Uyar I., Mansuroglu D., Kirali K., et al. Aspartate and glutamate-enriched cardioplegia in left ventricular dysfunction. J Card Surg 2005, 20:337-344.
85. Bitzikas G., Papakonstantinou C., Lazou A., et al. The supportive value of pre-bypass L-glutamate loading in patients undergoing coronary artery bypass grafting. J Cardiovasc Surg (Torino) 2005, 46:551-557.
86. Scarabelli T.M., Pasini E., Stephanou A., et al. Nutritional supplementation with mixed essential amino acids enhances myocyte survival preserving mitochondrial functional capacity during ischemia-reperfusion injury. Am J Cardiol 2004, 93:35A-40A.
87. Pasini E., Scarabelli T.M., D'Antona G., et al. Effect of amino acid mixture on the isolated ischemic heart. Am J Cardiol 2004, 93:30A-34A.
88. Venturini A., Ascioni R., Lin H., et al. The importance of myocardial amino acids during ischemia and reperfusion in dilated left ventricle of patients with degenerative mitral valve disease. Mol Cell Biochem 2009, 330:63-70.
89. Taegtmeyer H., Harinstein M.E., Gheorghiade M. More than bricks and mortar: comments on protein and amino acid protein in the heart. Am J Cardiol 2008, 101:3E-7E.
90. Suleiman M.S., Fernando H.C., Dihmis W.C., et al. A loss of taurine and other amino acids from ventricles of patients undergoing bypass surgery. Br Heart J 1993, 69:241-245.
91. Kaye D.M., Ahlers B.A., Autelitano D.J., et al. In vivo and in vitro evidence for impaired arginine transport in human heart failure. Circulation 2000, 102:2707-2712.
92. Visser M., Paulus W.J., Vermeulen M.A., et al. The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature. Eur J Heart Fail 2010, 12:1274-1281.
93. Wolfe B.M. Substrate-endocrine interactions and protein metabolism. JPEN J Parenter Enteral Nutr 1980, 4:188-194.
94. Witte K.K., Clark A.L., Cleland J.G. Chronic heart failure and micronutrients. J Am Coll Cardiol 2001, 37:1765-1774.
95. Wallis J., Lygate C.A., Fischer A., et al. Supranormal myocardial creatine and phosphocreatine concentrations lead to cardiac hypertrophy and heart failure: insights from creatine transporter-overexpressing transgenic mice. Circulation 2005, 112:3131-3139.
96. Ng T.M. Levosimendan, a new calcium-sensitizing inotrope for heart failure. Pharmacotherapy 2004, 24:1366-1384.
97. Zerr K.J., Furnary A.P., Grunkemeier G.L., et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997, 63(2):356-361.
98. Aquilani R., Opasich C., Verri M., et al. Is nutritional intake adequate in chronic heart failure patients?. J Am Coll Cardiol 2003, 42:1218-1223.
99. Vega J.D., Poindexter S.M., Radovancevic B., et al. Nutritional assessment of patients with extended left ventricular assist device support. ASAIO Trans 1990, 36:M555-M558.
100. Loebe M., Koster A., Sänger S., et al. Inflammatory response after implantation of a left ventricular assist device comparison between the axial flow MicroMed DeBakey VAD and the pulsatile Novacor device. ASAIO J 2001, 47(3):272-274.
101. Koster A., Loebe M., Hansen R., et al. Alterations in coagulation after implantation of a pulsatile Novacor LVAD and the axial flow MicroMed DeBakey LVAD. Ann Thorac Surg 2000, 70(2):533-537.
102. Itescu S., Ankersmit J.H., Kocher A.A., et al. Immunobiology of left ventricular assist devices. Prog Cardiovasc Dis 2000, 43(1):67-80.
103. Dang N.C., Topkara V.K., Kim B.T., et al. Nutritional status in patients on left ventricular assist device support. J Thorac Cardiovasc Surg 2005, 230(5):e3-e4.
104. Machado A.N., Sitta Mdo C., Jacob Filho W., et al. Prognostic factors for mortality among patients above the 6th decade undergoing non-cardiac surgery: CARES-clinical assessment and research in elderly surgical patients. Clinics (Sao Paulo) 2008, 63(2):151-156.
105. Fukuse T., Satoda N., Hijiya K., et al. Importance of a comprehensive geriatric assessment in prediction of complications following thoracic surgery in elderly patients. Chest 2005, 127:886-891.
106. Carney D.E., Meguid M.M. Current concepts in nutritional assessment. Arch Surg 2002, 137:42-45.
107. Isowa N., Hasegawa S., Bando T., et al. Preoperative risk factors for prolonged air leak following lobectomy or segmentectomy for primary lung cancer. Eur J Cardiothorac Surg 2002, 21:951.
108. Ollenschlager G., Schrappe-Bacher M., Steffan M., et al. Klin Wochenschr 1989, 67(21):1101-1107. [in German].
109. Merrigan B.A., Winter D.C., O'Sullivan G.C. Chylothorax. Br J Surg 1997, 84:15-20.
110. Machleder H.I., Paulus H. Clinical and immunological alterations observed in patients undergoing long-term thoracic duct drainage. Surgery 1978, 84:157-165.
111. Lagarde S.M., Omloo J.M., de Jong K., et al. Incidence and management of chyle leakage after esophagectomy. Ann Thorac Surg 2005, 80:449-454.
112. Bolger C., Walsh T.N., Tanner W.A., et al. Chylothorax after oesophagectomy. Br J Surg 1991, 78:587-588.